We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Agronomics Limited | LSE:ANIC | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.10 | 1.28% | 7.90 | 1,762,061 | 11:15:27 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 7.80 | 8.00 | 7.90 | 7.82 | 7.85 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investors, Nec | 30.88M | 22.37M | 0.0222 | 3.56 | 79.74M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:35:09 | UT | 45,000 | 7.90 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/4/2024 | 07:00 | UK RNS | Agronomics Limited Agronomics Newsletter |
| 17/4/2024 | 13:03 | ALNC |  Agronomics portfolio firm raises EUR40 million to scale up production |
| 17/4/2024 | 07:00 | UK RNS | Agronomics Limited Mosa Meat Raises EUR 40 Million in New Financing |
| 12/4/2024 | 07:00 | UK RNS | Agronomics Limited Exercise of Warrants |
| 10/4/2024 | 09:30 | UK RNS | Agronomics Limited Portfolio Company Presentation Series – Onego Bio |
| 05/4/2024 | 11:50 | ALNC | IN BRIEF: Agronomics invests extra USD10 million in Liberation Labs |
| 05/4/2024 | 07:00 | UK RNS | Agronomics Limited Agronomics Invests US$10m in Liberation Labs |
| 02/4/2024 | 15:19 | ALNC | TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout |
| 02/4/2024 | 07:00 | UK RNS | Agronomics Limited Onego Bio Raises EUR37 Million |
| 26/3/2024 | 12:39 | ALNC | Agronomics' Clean Food Group secures GBP2.5 million in funding |
Agronomics (ANIC) Share Charts1 Year Agronomics Chart |
|
1 Month Agronomics Chart |
Intraday Agronomics Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 23/4/2024 | 17:08 | Agronomics -ANIC- Clean shell, Heavyweight Board, Ready for Action | 1,706 |
| 17/4/2024 | 07:53 | AGRONOMICS: A Cellular Agriculture Investment Portfolio | 196 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-04-24 15:35:09 | 7.90 | 45,000 | 3,555.00 | UT |
| 2024-04-24 15:29:11 | 7.92 | 1,314 | 104.05 | O |
| 2024-04-24 15:27:32 | 7.90 | 250,000 | 19,750.00 | O |
| 2024-04-24 15:06:46 | 7.86 | 113 | 8.88 | O |
| 2024-04-24 14:45:39 | 8.00 | 50,000 | 4,000.00 | O |
| Top Posts |
|---|
Posted at 24/4/2024 09:20 by Agronomics Daily Update Agronomics Limited is listed in the Investors, Nec sector of the London Stock Exchange with ticker ANIC. The last closing price for Agronomics was 7.80p.Agronomics currently has 1,009,408,091 shares in issue. The market capitalisation of Agronomics is £79,743,239. Agronomics has a price to earnings ratio (PE ratio) of 3.56. This morning ANIC shares opened at 7.85p |
Posted at 02/4/2024 10:31 by 1chrism Id not heard of ITX before, really interesting company. I see your point and think it does make sense, especially around meat and especially in the US. The declining share price will most definitely have been impacted by the bible belt reaction. Unlike ITX of course, ANIC are not revenue creating at the moment.And in terms of the notion of consumer uptake, ANIC are not reliant on meat and both Mellon and Chow are upfront about the notion that lab meat is a 10 yeqr hence thing. The media just carried away following Good meat and Upside approvals last year.I think that because of interest rates investors are rightly nervous about AIM at the moment and wont care or even notice ANIC until sometime next year when Liberation Labs is operational Meatly have upscalled and they realise BlueNalu works.If you are in ANIC now you are 5 years early to the party |
Posted at 02/4/2024 09:47 by 1chrism The second successful fundraise by a ANIC investee in as many weeks. This time £37m Euro for Onego Bio.Share price predictably immovable. Im more worried for AIM than ANIC at this point. Which by extension is a worry for ANIC. It really does look like London has taken the interest rate problem personally. |
Posted at 25/3/2024 12:22 by 1chrism Whilst irritating, I think leaning on the buyback as some indicator of the value of the business is a red herring. I'd agree that it was a mistake for ANIC to even suggest it given current macro.It is worth reminding ourselves that ANIC have 20+ companies all marching towards commercialism in a sector that first has to go through approval. With the additional burden of taking flack from the industry (intensive farming) their product will eventually supplant.Also worth reminding ourselves that ANIC is led by Jim Mellon who is treating this as a life ambition. They wont ever be short of money, neither will they be worried when the landscape is better for fundraising.Mellon was recently interviewed and was quite open about the share price, trajectory of the company and the projects invested therein. I'll link and include notes later. But suffice to safe, investing in ANIC is not a 1,2 or even 5 year play. It is easily 10 years minimum. Likely some companies wont make it. But, they founded Meatly and Liberation Labs, and whilst the former may have one more regulatory hurdle to clear the latter is without competition with a clear runway. |
Posted at 22/3/2024 07:23 by 1chrism ANIC Supermeat rns was great for the industry but made little impact in the market. I suspect until ANIC start talking about commercial sales we can expect more of the same. Meaning q2 2025 will be a bit more positive for the share price in terms of ANIC reporting on sales. Otherwise ANIC are the proverbial reed in the macro wind.However under the radar FSA anouncement went, the commitment to change novel food approval process is a boost for commercial viability of cellular agriculture in the UKhttps://cultivated |
Posted at 04/3/2024 11:29 by 1chrism Santa rally. Bad macro outlook and a portfolio gearing up for commercialisation means that for the next two years ANIC is going to be like the proverbial reed in the wind when it comes to share price. Im in ANIC and happy to stay for 20 years, there is currently zero competition. But if I was looking for a quick six month win I would go elsewhere, the share price will go where the macro tells it to for the next couple of years. |
Posted at 04/3/2024 11:07 by 1chrism I do agree that it is a frustration and I've written off the likelihood as a non starter. I think also to underline a share buyback as demonstrative of inaction is a complete non starter. Lots of things are happening.Liberation Labs are building a factory, BluNalu has a stellar board and contracts with all big fishing commercial outlets in Asia and I recommend you watch the Meqtly capital markets day presentation, they are progressing to commercialisation with rapidity.Investing in ANIC is the definition of a long term play. And whilst AIM remains the least loved child of the world's stock market downward pressure on the share price will be sustained. Nothing material has changed with the timelines for ANICs portfolio companies. As tempting as it can be to lean on a share buyback deadline as definitive I think focus on the companies operating under the fund will give us a greater degree of certainty on the share price trajectory. |
Posted at 16/2/2024 16:07 by 1chrism My word, what happened to the editorial team, that was a long read. On the whole though, it is the tone rather than the content that builds the suspense. In ANIC portfolio for example all meat companies (Mosa, Meatable eve Blue Nalu) recognise that price parity and market share is a decade or so off. Anthony Chow and Jim Mellon are consistent on this especially over the last 12 months. The response to lab meat seems to be either a surprise that it is not in circulation or suspicion that it is going to put all farmers out of work. But, there have been only two companies hit the dinner plate in the US. Singapore, there are more but it really is like we are witnessing the invention of the motor car or quill. It is very new. Very, very new.All ANIC companies in meat (and probably in general) need to work on reduction of media (the liquid in which the meat grows). ANIC companies like Meatly have reduced cost from £700 to around £1. But still need to reduce by around 90%. It is going to happen, but not at the pace of the author of the article you kindly shares would seem to expect.And let us remember, cellular agriculture is not just meat. It is a quarter of ANIC portfolio. Added to that when it comes to meat, it sea food kind that is probably most exciting in ANIC portfolio; Blue Nalu have MOUs with major players in Thailand, Japan and South Korea and PIF on board. Now that is really exciting.I think it is a very useful article but overly reactionary on a sector that is still finding its feet. |
Posted at 07/11/2023 08:27 by davebowler CANACCORD -Positive NAV momentum On Friday, Agronomics reported its 30 September 2023 financials. The company's NAV/ share has increased by 4% to 16.48 pence from the last reported value of 15.80 pence in June 2023, manifesting the fruits of its shrewd investment strategy in cellular agriculture. The net assets now stand at £164 million, underpinned by a £140 million investment portfolio, complemented by c.£24 million in cash. Despite the venture capital climate being constrained by economic uncertainties, Agronomics has recently closed several funding rounds on its portfolio companies, indicative of the portfolio's resilience and continued growth potential. We remain BUYers with an unchanged target price of 20p. We continue to expect progressive growth as the cellular agriculture sector, particularly precision fermentation, evolves; we note the sector is still attracting new investment rounds at progressively more robust valuations. Trading: 40% discount to NAV Agronomics' share valuation in the market is currently at a substantial discount to NAV, exceeding 40% as per the last close price. We note that approximately 30% of ANIC's NAV is based on transaction values over the past 12 months, and we note continued successful transactions. £3mn in buyback In light of the discrepancy between NAV/share value and share price, the company has launched a discretionary share buyback programme for up to £3 million, which began on 2 October 2023. This six-month initiative aims to recalibrate the share price to reflect the company's worth and enhance the NAV per share. Portfolio developments and financial position Portfolio highlights include Meatable's successful c.€30 million Series B round, with Agronomics' €4mn investment now valued at £11.8 million, inclusive of an unrealised gain of £3.9 million. Clean Food Group also completed a £2.3 million Pre-Series A round, with Agronomics contributing £0.7 million, now valued at £6.97 million, evidencing a significant IRR. This investment propels Clean Food Group to construct a new UK facility. With a substantial cash reserve, we believe Agronomics is strategically positioned to capitalise on cellular agriculture opportunities without immediate fundraising. Valuation: no changes We continue to base our valuation on the estimated NAV at the end of next quarter (December 2023), factoring in Agronomics' established proficiency in increasing the value of its portfolio. We reiterate our target price of 20p, which would make the stock trade at a ratio of c.1.2 times our projected NAV for December 2023. We remain BUYers. |
Posted at 13/10/2023 09:46 by 1chrism ANIC is an easy target for a seller on current trend. ANIC companies are all pre revenue and majority will be like this until 2025. Add interest rates into the mix, the apetite is for say defensive stocks. And we have probably have a recession round the corner.But, there is no other investment trust for cell ag. that can compete. All companies have a clear and realistic pathway to commercialisation. Blue Nalu recent strategic partnerships are a great example.Id expect the share price to drop until interest rates srart improving. Even if/when Good Dog Food does the pet food equivalent of inventing the car I'm fully expecting no market reaction.So long as cash balance remains healthy and investment strategy realistic the share price trajectory is no different to nearly all AIM listed companies. You only need to note AIM all share price which is back to 2016 lows at least. |
Posted at 24/9/2023 11:09 by quepassa I think the Share BuyBack Program is a great idea.But the RNS was pretty unclear and/or unconvincing on the mechanics of the programme on TWO POINTS. 1. It says that the Board has to approve each and every purchase. It is not clear whether the Board approval is needed ( as I suspect) PRIOR to any market purchase of shares by their broker or after the event. If Board approval is required PRIOR to each purchase - what are they going to do? Convene a quorate Board meeting each and every time the broker rings them up? If so, it doesn't sound very workable or practical to me with 5 Board Members to consult/vote. 2. I think they have also badly shot themselves in the foot as one of the pricing conditions is that they WILL NOT pay higher than 75% of last reported quarterly NAV. That means no higher than 75% of last NAV of 15.8p which is 11.85p - being the current max they will pay. Not really a heck of a lot of upside to the current share price I interpret this in the vein that they EXPECT the share price to continue trade at a D2N of at least 25%. That doesn't sound very upbeat about the future prospects for the discount to narrow if their low ambitions are just to move the current discount of c 37% to 25%. Yes, many specialist vehicles in illiquid investments do trade at significant discounts but some at much tighter discounts than 25%. ------- The mechanics of many SBP's can be over-complicated, unwieldy and too restrictive. And I fear that this is one of them. It is not a convincing SBP in my opinion. Another specialist investment vehicle Seraphim Space (ticker SSIT) recently announced (RNS 13/7) an SBP which was the clearest and most straightforward I have ever seen. And they have been buying back nearly every day since their announcement. The max they will pay is 100% of NAV. Fair enough. Ambitious. Jim Mellon should take a look at it and what has happened to SSIT's share price as a result. The results of SSIT's SBP have been to DOUBLE the share price in just two months. Sorry but I don't think ANIC's SBP is a very convincing one.They should think about revising it in my view, if they are serious about it. ALL IMO. DYOR. QP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
